Back to search
FDAFDA · Food and drugs·Recall number D-0291-2026

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Published January 28, 2026 · Recall initiated: December 22, 2025

Summary

FDA records drug Class III recall D-0291-2026, published January 28, 2026 and initiated December 22, 2025. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: 92,376 tubes; Lot: Batch XHBG; Exp. 08/31/2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed PH Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if DICLOFENAC SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DICLOFENAC SODIUM
Manufacturer
Cipla USA, Inc.
Distributor
Nationwide in the USA
Lot
Batch XHBG; Exp. 08/31/2027
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 recalled?

Yes. FDA published recall D-0291-2026 on January 28, 2026. Reported hazard: Failed PH Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DICLOFENAC SODIUM.